This study shows the accuracy of exclusive or earlier growth in anaerobic vials to predict Candida glabrata in a large series of candidemic patients from two European hospitals using the Bactec 9240 system. Alternatively, C. glabrata can be predicted by a time to positivity cutoff value, which should be determined for each setting.
T he time to positivity (TTP) has been successfully exploited as a tool for the presumptive identification of the species or type of microorganism involved in bacteremia (1) (2) (3) (4) (5) . In patients with candidemia, the TTP has been reported to be longer for Candida glabrata than for other Candida species in BacT/Alert (6, 7) and Bactec 9240 systems (8) (9) (10) . Previous works showed that C. glabrata is particularly prone to grow in anaerobic blood culture vials (11, 12) , and two clinical studies reported that an exclusive or earlier growth in anaerobic vials is useful for predicting C. glabrata (8, 13) . However, while both clinical studies showed a high specificity, the sensitivity was 37% in one and 95% in the other. This raises a concern about the usefulness of this rule in different clinical settings.
Data on the TTP of consecutive patients with monomicrobial candidemia were collected in two European 700-and 1,400-bed university hospitals located in Barcelona (Spain) and Cologne (Germany), respectively. The Barcelona center provided data from 1 January 2008 to 31 March 2012 and the Cologne center from 1 August 2006 to 31 December 2011. The ethics committee of Hospital Clinic de Barcelona approved the study. Only the first set of positive blood cultures was included, and the shortest TTP (measured in hours) registered for any positive aerobic and anaerobic vials were analyzed.
In Barcelona, blood cultures were processed by the Bactec 9240 system (Becton-Dickinson, MD, USA), and vials were loaded into the machine around the clock. In Cologne, blood cultures were processed by the same system, but vials were placed into the system only during the working hours of the laboratory. The vials used in Barcelona were the resin-containing Bactec Plus Aerobic/F and Bactec Plus Anaerobic/F or the non-resin-containing Bactec Standard 10 Aerobic/F and Bactec Lytic/10 Anaerobic/F. In Cologne, only resin-containing vials were used.
Comparisons of TTP between species were carried out using the Student t test. Proportions were compared by Fisher's exact test. A receiver operating characteristic (ROC) curve was used to assess the diagnostic accuracy of TTP for C. glabrata and to identify the optimal cutoff value.
A total of 379 episodes of monomicrobial candidemia were The test characteristics for predicting C. glabrata either by the exclusive or earlier growth in anaerobic vials (primary test) or by TTP cutoff values (alternative test) are shown in Table 3 . In regard to the primary test, there were no significant differences between Cologne and Barcelona in either sensitivity (31% versus 37%, P ϭ 0.6) or specificity (99% versus 96%, P ϭ 0.14). Given its low sensitivity, the alternative rule may be appropriately used in patients in whom the first test is negative. When yeast was detected exclusively or first in aerobic vials, a TTP of Ͼ56.5 h in Barcelona and a TTP of Ͼ79 h in Cologne had positive predictive values (PPVs) for C. glabrata of 30% and 69%, respectively. In the two sites, the corresponding negative predictive value (NPV) was 96%. A twostep diagnostic approach using the primary test in the whole population and then the alternative test in cases with exclusive or first detection in aerobic vials had 79% sensitivity, 90% specificity, 59% PPV, and 96% NPV.
This study shows that exclusive or earlier detection of growth in anaerobic vials by the Bactec 9240 system can predict the presence of C. glabrata with high specificity. The sensitivity found in the present study (31% to 38%) was much lower than the 95% described by Foster et al. (13) . This increased sensitivity was probably due to the systematic use by Foster et al. of the Lytic/10 Anaerobic/F culture vials instead of the regular Bactec anaerobic vials used in the present study. However, earlier or exclusive detection in anaerobic vials increased the likelihood of C. glabrata from pretest probabilities of 12% in Barcelona and 17% in Cologne to posttest probabilities of 58% and 86%, respectively.
An unexpected finding of this study was the difference in the mean TTP of C. glabrata between the two sites. Potential explanations are an unequal distribution of catheter-related candidemia between sites and different proportions of patients undergoing antifungal therapy at the time when blood samples for culture were drawn. In any case, our data indicate caution about the use of absolute cutoff values for TTP in predicting C. glabrata as has been proposed in other studies (8) (9) (10) .
Our results suggest that a two-step approach, using first the test less prone to be affected by confounders (earlier or exclusive detection in anaerobic vials) followed by the site-specific TTP cutoff test in those cases with earlier or exclusive detection in an aerobic vial, has the highest sensitivity (79%) and NPV (96%).
This study had several limitations. First of all, we did not assess variables that may have influenced TTP, such as ongoing antimicrobial therapy, the source of candidemia, and the clinical conditions of the patients (2). Furthermore, the clinical impact of changing the empirical treatment with the result of the Gram stain could not be assessed. Finally, as the BacT/Alert system may have better yields and shorter TTP for C. glabrata (12) , our results cannot be extrapolated to other incubation systems or type of vials. 
